Horizon Global Announces Receipt of Continued Listing Standard Notice From the NYSE
Horizon Global Corporation (NYSE: HZN) (the "Company") announced today that it received a notice November 7, 2022 (the "Notice") from the New York Stock Exchange (the "NYSE") indicating that the Company is no longer in compliance with Section 802.01C of the NYSE Listed Company Manual because the average closing price of the Company's common stock was less than $1.00 per share over a consecutive 30 trading-day period
PLYMOUTH, Mich.--(BUSINESS WIRE)--Nov 11, 2022--
Horizon Global Corporation (NYSE: HZN) (the "Company") announced today that it received a notice November 7, 2022 (the "Notice") from the New York Stock Exchange (the "NYSE") indicating that the Company is no longer in compliance with Section 802.01C of the NYSE Listed Company Manual because the average closing price of the Company's common stock was less than $1.00 per share over a consecutive 30 trading-day period.
The Company will notify the NYSE of its intent to cure the stock price deficiency and return to compliance with the continued listing standard. The Company can regain compliance at any time within the six-month cure period following receipt of the Notice, if, on the last trading day of any calendar month during the cure period, the Company's common stock has a closing share price of at least $1.00 and an average closing share price of at least $1.00 over the 30 trading-day period ending on the last trading day of that month. Horizon Global intends to closely monitor its stock price during the cure period and will, if necessary, consider available alternatives to cure the stock price non-compliance.
The Company's common stock will continue to be listed and traded on the NYSE during the cure period, subject to the Company's compliance with other NYSE continued listing standards.
